[1]
Baghrous , S. et al. 2025. Beyond Current Therapies: In Silico Drug Repurposing as a Strategy to Overcome Tyrosine Kinase Inhibitor Resistance in NSCLC. Journal of Drug Delivery and Therapeutics. 15, 8 (Aug. 2025), 207–216. DOI:https://doi.org/10.22270/jddt.v15i8.7276.